ArticleFrontiers in oncology2025

Reporting of immune-related adverse events in US Food and Drug Administration approvals of immune checkpoint inhibitors.

Shaili Tapiavala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.